Literature DB >> 16519671

Vesicular glutamate transporter 3 (VGLUT3) identifies spatially segregated excitatory terminals in the rat substantia nigra.

Raquel Martín-Ibañez1, Monica Jenstad, Paul Berghuis, Robert H Edwards, Hiroyuki Hioki, Takeshi Kaneko, Jan Mulder, Josep M Canals, Patrik Ernfors, Farrukh A Chaudhry, Tibor Harkany.   

Abstract

The excitability of dopaminergic (DA) neurons in the substantia nigra is controlled by the convergent activity of multiple glutamatergic afferents. Here, we show that vesicular glutamate transporter 3 (VGLUT3)-immunoreactive (ir) terminals segregate to the perisomatic region of DA neurons in the substantia nigra pars compacta, and VGLUT3 decorates a synapse population distinct from those marked by vesicular glutamate transporters 1 and 2. VGLUT3-ir nerve endings form asymmetric terminals on DA neurons. Retrograde tracing suggests the superior colliculus as an origin of excitatory VGLUT3-ir afferents. Collectively, our data indicate that VGLUT3 identifies a novel excitatory terminal subset that contributes to the tuning of DA cell excitability in the substantia nigra.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16519671     DOI: 10.1111/j.1460-9568.2006.04601.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  8 in total

Review 1.  From glutamate co-release to vesicular synergy: vesicular glutamate transporters.

Authors:  Salah El Mestikawy; Asa Wallén-Mackenzie; Guillaume M Fortin; Laurent Descarries; Louis-Eric Trudeau
Journal:  Nat Rev Neurosci       Date:  2011-04       Impact factor: 34.870

2.  WNT signaling in activated microglia is proinflammatory.

Authors:  Carina Halleskog; Jan Mulder; Jenny Dahlström; Ken Mackie; Tibor Hortobágyi; Heikki Tanila; Lakshman Kumar Puli; Katrin Färber; Tibor Harkany; Gunnar Schulte
Journal:  Glia       Date:  2010-10-21       Impact factor: 7.452

3.  Secretagogin is a Ca2+-binding protein specifying subpopulations of telencephalic neurons.

Authors:  Jan Mulder; Misha Zilberter; Lauren Spence; Giuseppe Tortoriello; Mathias Uhlén; Yuchio Yanagawa; Fabienne Aujard; Tomas Hökfelt; Tibor Harkany
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-16       Impact factor: 11.205

4.  Brain-wide genetic mapping identifies the indusium griseum as a prenatal target of pharmacologically unrelated psychostimulants.

Authors:  Janos Fuzik; Sabah Rehman; Fatima Girach; Andras G Miklosi; Solomiia Korchynska; Gloria Arque; Roman A Romanov; János Hanics; Ludwig Wagner; Konstantinos Meletis; Yuchio Yanagawa; Gabor G Kovacs; Alán Alpár; Tomas G M Hökfelt; Tibor Harkany
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-03       Impact factor: 11.205

5.  Conditional BDNF release under pathological conditions improves Huntington's disease pathology by delaying neuronal dysfunction.

Authors:  Albert Giralt; Olga Carretón; Cristina Lao-Peregrin; Eduardo D Martín; Jordi Alberch
Journal:  Mol Neurodegener       Date:  2011-10-10       Impact factor: 14.195

6.  K-ATP channels in dopamine substantia nigra neurons control bursting and novelty-induced exploration.

Authors:  Julia Schiemann; Falk Schlaudraff; Verena Klose; Markus Bingmer; Susumu Seino; Peter J Magill; Kareem A Zaghloul; Gaby Schneider; Birgit Liss; Jochen Roeper
Journal:  Nat Neurosci       Date:  2012-08-19       Impact factor: 24.884

7.  Axonal Segregation and Role of the Vesicular Glutamate Transporter VGLUT3 in Serotonin Neurons.

Authors:  Aurore N Voisin; Ouissame Mnie-Filali; Nicolas Giguère; Guillaume M Fortin; Erika Vigneault; Salah El Mestikawy; Laurent Descarries; Louis-Éric Trudeau
Journal:  Front Neuroanat       Date:  2016-04-12       Impact factor: 3.856

Review 8.  A New Player in the Hippocampus: A Review on VGLUT3+ Neurons and Their Role in the Regulation of Hippocampal Activity and Behaviour.

Authors:  Csilla Lea Fazekas; Adrienn Szabó; Bibiána Török; Krisztina Bánrévi; Pedro Correia; Tiago Chaves; Stéphanie Daumas; Dóra Zelena
Journal:  Int J Mol Sci       Date:  2022-01-12       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.